.org/treatment/hormonal/what_is_it/hormone_role.jsp.
(Last accessed October 2007)
5. Cella et al, Quality of life of postmenopausal women in the ATAC
('Arimidex', Tamoxifen, Alone or in Combination) trial after completion
of 5 years' Adjuvant Treatment for early breast cancer. Breast Cancer
Research and Treatment, 2006. 100(3): p. 273-284.
6. Data on file, 'More Positive Conversations' global survey, conducted by
Harris Interactive (US) March-May 2007.
"The greatest fear for women who have been treated for early breast
cancer is to have their cancer return, which ultimately means their disease
is incurable. However, these new data show that with anastrozole, women
have the best possible chance yet to live cancer-free - even after their
treatment has finished." Professor Lesley Fallowfield, Director, Cancer
Research UK Psychosocial Oncology Group, University of Sussex, UK
'/>"/>SOURCE AstraZeneca Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine technology :1.
Video: New Research Discovers Independent Brain Networks Control Human Walking2.
Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression3.
Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies4.
Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign5.
Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease6.
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain7.
Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate8.
Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet9.
DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,94710.
Tapestry Reports Second Quarter 2007 Results11.
Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results